Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: epigastric pain radiating to back major surgical or invasive procedure: endovascular stent graft of descending thoracic aorta. history of present illness: 75 yo f s/p ascending aorta and hemiarch replacement and resuspension of av in . presented to ed on with epigastric pain radiating to the back and n/v. cta showed penetrating ulcer of descending thoracic aorta, size of aorta at level of ulcer 5.7 cm and muralthrombus from level of ulcer to celiac trunk. past medical history: 1. aneurysm of ascending aorta and aortic arch, s/p repair 2. tortuous dilated thoracic aorta. 3. hocm- lvot 10mmhg cath , tte: lvot 19mmhg, 1+ar, 1+mr 4. h/o dysphagia with aneurysm 5. l vocal cord dysphagia- 6. hypertension. 7. hypercholesterolemia. 8. diabetes mellitus, type 2. 9. hypothyroidism. 10. glaucoma. 11. osteoarthritis. 12. osteopenia 13. status post total abdominal hysterectomy. 14. status post colonic polypectomy. 15. h/o left nasolabial abscess () social history: h/o mild tobacco, quit . no etoh/drugs. lives alone, does own shopping, adls. family history: father deceased cancer, mother died in childbirth. physical exam: elderly f in nad 98.2 68 132/80 18 97% on 2l lungs ctab cv rrr without m/r/g abdomen soft/nt/nd extrem without c/c/e, pulses 2+ t/o neuro grossly intact pertinent results: 05:25am blood wbc-9.6 rbc-3.79* hgb-10.8* hct-32.2* mcv-85 mch-28.6 mchc-33.7 rdw-15.8* plt ct-313 09:30pm blood wbc-8.4# rbc-5.20 hgb-14.9 hct-41.2 mcv-79* mch-28.5 mchc-36.1* rdw-16.1* plt ct-219 05:25am blood plt ct-313 01:45am blood pt-15.6* ptt-29.7 inr(pt)-1.4* 09:30pm blood plt ct-219 05:25am blood glucose-48* urean-11 creat-0.6 na-142 k-3.9 cl-104 hco3-34* angap-8 09:30pm blood glucose-108* urean-12 creat-0.9 na-140 k-3.7 cl-101 hco3-30 angap-13 02:05am blood alt-17 ast-19 ld(ldh)-256* ck(cpk)-85 alkphos-65 amylase-55 totbili-0.8 chest (portable ap) 5:34 pm chest (portable ap) reason: eval edema, effusions medical condition: 75 year old woman s/p taaa stent reason for this examination: eval edema, effusions history: status post aaa stent. findings: in comparison with the study of , there is no change in the appearance of the heart and lungs. mild blunting of the left costophrenic angle is suggested. endotracheal tube and central catheter have been removed. cta chest w&w/o c&recons, non-coronary 10:39 am cta chest w&w/o c&recons, non-; cta abd w&w/o c & recons reason: eval hematoma in pt with slowly dropping hct medical condition: 75 year old woman s/p descending aortic stent graft placement reason for this examination: eval hematoma in pt with slowly dropping hct contraindications for iv contrast: none. cta of the chest clinical history: 75-year-old woman, status post descending aortic stent graft replacement with retroperitoneal hematoma and slowly dropping hematocrit. technique: mdct-acquired axial images were initially obtained through the chest and abdomen without contrast, followed by contrast-enhanced images through the chest, abdomen, and pelvis after administration of 100 cc of intravenous optiray. comparison: . findings: ct of the chest: there is marked diffuse enlargement of the thyroid gland, particularly the left thyroid lobe, most compatible with multinodular goiter. surgical clips are present in the anterior mediastinum. the previously noted graft in the ascending aorta is stable in appearance. the ascending aorta measures 3.9 x 4.0 cm at the level of the main pulmonary artery. the previously noted stent graft extending from the aortic arch into the proximal abdominal aorta is stable in appearance. there is a persistent crescentic pooling of contrast along the medial aspect of the stent compatible with an endoleak. this is not significantly changed from the prior examination. there is no mediastinal hematoma. the previously noted small left pleural effusion has resolved. the lungs are clear with the exception of several small scattered areas of subsegmental plate-like atelectasis. ct of the abdomen: the liver is normal in size and contour. high-density material is seen in the gallbladder compatible with vicarious excretion of the contrast. the spleen, pancreas, adrenal glands, and kidneys are unchanged. a simple renal cyst is again noted in the left kidney measuring approximately 3.6 cm in greatest dimension. the celiac and superior mesenteric arteries are patent. the small and large bowel are normal in caliber. the previously noted right retroperitoneal hematoma has increased in size and now measures 8.8 cm in transverse, 9.1 cm in ap, and 18 cm in craniocaudal dimension. additionally, multiple hyperdense components are now identified within the hematoma suggestive of rebleeding. a small component of the hematoma is extending medially as before to the region of the right common iliac pseudoaneurysm. however, no active contrast extravasation is identified in this region. the previously identified pseudoaneurysm which arises at the level of the bifurcation of the right common iliac artery and right external iliac artery is unchanged in appearance and measures approximately 1.3 cm in diameter. the external and internal iliac arteries are patent bilaterally. there has been slight interval decrease in subcutaneous emphysema along the right anterior abdominal wall. midline surgical staples are again noted. there is asymmetric thickening of the right rectus abdominis muscle and somewhat increased attenuation likely reflecting an intramuscular hematoma in this region. ct of the pelvis: the urinary bladder is unremarkable. there is no significant free pelvic fluid. bone windows: no suspicious lytic or sclerotic lesions are identified. impression: 1. interval increase in the size of the right retroperitoneal hematoma which now also contains new hyperdense components suggestive of more accute hemorrhage. since no precontrast images are availble through the region of hematoma,evaluation for active contrast extravasation cannot be accurately done. 2. intramuscular hematoma involving the right rectus abdominis muscle, probably minimall increase since the prior study. 3. no significant change in appearance of the thoracic stent graft and previously noted endoleak. no evidence of mediastinal hematoma. echocardiography report , a (complete) done at 4:04:15 pm preliminary referring physician information , division of cardiothoracic , status: inpatient dob: age (years): 73 f hgt (in): 66 bp (mm hg): 154/84 wgt (lb): 157 hr (bpm): 53 bsa (m2): 1.81 m2 indication: intra-op tee for thoracic aortic stent icd-9 codes: 440.0, 441.2, 424.1 test information date/time: at 16:04 interpret md: , md, md test type: tee (complete) son: , md doppler: full doppler and color doppler test location: anesthesia west or cardiac contrast: none tech quality: adequate tape #: 2008aw210-0:0 machine: echocardiographic measurements results measurements normal range left ventricle - septal wall thickness: *1.2 cm 0.6 - 1.1 cm left ventricle - inferolateral thickness: *1.2 cm 0.6 - 1.1 cm left ventricle - diastolic dimension: 5.0 cm <= 5.6 cm left ventricle - ejection fraction: 60% >= 55% aorta - descending thoracic: *4.2 cm <= 2.5 cm findings right atrium/interatrial septum: normal interatrial septum. no asd by 2d or color doppler. left ventricle: mild symmetric lvh. normal lv cavity size. overall normal lvef (>55%). right ventricle: normal rv chamber size and free wall motion. aorta: simple atheroma in aortic arch. moderately dilated descending aorta aortic valve: mildly thickened aortic valve leaflets (3). mild (1+) ar. mitral valve: mildly thickened mitral valve leaflets. mild thickening of mitral valve chordae. calcified tips of papillary muscles. physiologic mr (within normal limits). tricuspid valve: normal tricuspid valve leaflets with trivial tr. pulmonic valve/pulmonary artery: normal pulmonic valve leaflets with physiologic pr. general comments: a tee was performed in the location listed above. i certify i was present in compliance with hcfa regulations. the patient was under general anesthesia throughout the procedure. no tee related complications. conclusions 1. no atrial septal defect is seen by 2d or color doppler. 2. there is mild symmetric left ventricular hypertrophy. the left ventricular cavity size is normal. overall left ventricular systolic function is normal (lvef>55%). 3. right ventricular chamber size and free wall motion are normal. there are simple atheroma in the aortic arch. the descending thoracic aorta is moderately dilated with noted intramural hematoma. there is an ulceration in the descending thoracic aorta. 4. the aortic valve leaflets (3) are mildly thickened. mild (1+) aortic regurgitation is seen. 5. the mitral valve leaflets are mildly thickened. physiologic mitral regurgitation is seen (within normal limits). brief hospital course: she was admitted to the cardiac surgery icu and started on a labetalol drip. she complained of pain despite blood pressure control and was taken to the operating room on where she underwent placement of an endovascular stent graft of the descending thoracic aorta. she was transferred to the icu in stable condition. she was extubated on pod #1. she was transferred to the floor on pod #2. ct scan showed large retroperitoneal bleed and type 2 endoleak. her hct was 22 and she was transfused. repeat cta showed increase in size of rp hematoma with ? of active hemorrhage. she was transferred back to the icu. she remained in the icu for frequent hematacrit checks. she remained stable and was transferred back to the floor. she developed an ileus, however her nausea improved, she is moving her bowels and tolerating a diet. she was ready for discharge home on pod #10. medications on admission: levoxyl 50', glipizide 5', latanoprost 0.005'. pilocarpine 0.5 2 gtts tid, dorzolamide-timolol 2-0.5", vasotec 30' discharge medications: 1. dorzolamide-timolol 2-0.5 % drops sig: one (1) drop ophthalmic (2 times a day). 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*0* 3. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*0* 4. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 5. pilocarpine hcl 0.5 % drops sig: two (2) drop ophthalmic q8h (every 8 hours). 6. latanoprost 0.005 % drops sig: one (1) drop ophthalmic hs (at bedtime). 7. levothyroxine 50 mcg tablet sig: one (1) tablet po daily (daily). 8. glipizide 5 mg tablet sig: one (1) tablet po daily (daily). 9. hydromorphone 4 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed. disp:*50 tablet(s)* refills:*0* 10. metoprolol tartrate 25 mg tablet sig: one (1) tablet po tid (3 times a day). disp:*90 tablet(s)* refills:*0* discharge disposition: home with service facility: homecare discharge diagnosis: penetrating ulcer in the descending thoracic aorta s/p aortic stent graft retroperitoneal bleed pmh: htn, s/p asc. aorta hemiarch replacement with resuspension of av , ^chol., dysphagia, niddm, hypothyriodism, glaucoma, oa, osteopenia, s/p tah s/p colonic polypectomy, s/p i+d of nasal abcess discharge condition: good. discharge instructions: call with fever, redness or drainage from incision or weight gain more than 2 pounds in one day or five in one week. shower, no baths, no lotions, creams or powders to incisions. no driving while taking pain medicine. p instructions: dr. 2 weeks dr. 4 weeks/dr. 4 weeks with cta torso procedure: aortography endovascular implantation of graft in thoracic aorta diagnoses: anemia, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hemorrhage complicating a procedure thoracic aneurysm, ruptured other complications due to other vascular device, implant, and graft paralytic ileus 

Answer: The patient is high likely exposed to